Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel Cu/Ir synergistic catalysis for stereo-diverse tetrahydro-γ-carbolines. High yield, mild conditions, scalable pharmaceutical intermediate manufacturing.
Patent CN113354554B details an efficient Iridium-catalyzed asymmetric hydrogenation route for carbapenem intermediates, offering superior stereoselectivity and scalable manufacturing capabilities.
Patent CN102952128B details a high-purity Vinpocetine refining method ensuring supply chain stability and cost reduction in pharmaceutical manufacturing.
Novel activation-condensation route for Sitagliptin intermediates. High yield, industrial scalability, cost-effective alternative to HOBt/EDC methods.
Patent CN106995467A reveals microwave synthesis for Bicycloplatin. Discover cost reduction in pharmaceutical manufacturing and reliable supply chain solutions.
Patent CN104829599A reveals efficient Ledipasvir synthesis reducing impurities. Discover cost-effective manufacturing and scalable supply chain solutions for high-purity intermediates.
Advanced synthesis of 5-ethyl-5-isoamylmalonyl urea via patent CN111606862A. Optimized methoxide route ensures high purity, reduced waste, and reliable supply chain for global pharmaceutical manufacturers.
Patent CN102311339B reveals a streamlined hydrolysis-rearrangement route for Vitamin A intermediates, offering significant cost reduction and supply chain reliability for global manufacturers.
Patent CN106866769A reveals high-yield pseudo-ginsenoside production. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN101654416A details a scalable synthesis for anticancer intermediates, offering improved yields and safer processing compared to traditional nitro-reduction methods.
Patent CN106554363A reveals a streamlined route for Baricitinib intermediates, eliminating protection steps to enhance supply chain reliability and reduce manufacturing costs significantly.
Patent CN102363599A reveals a robust chiral resolution method for sitagliptin intermediates using D-di-p-toluoyl tartrate, offering significant cost reduction and scalable manufacturing for pharmaceutical supply chains.
Patent CN117586317A reveals a novel methylation process achieving over 98% purity. This method offers significant supply chain stability and cost reduction advantages.
Patent CN112110811B details a novel Pd-catalyzed route for bilastine intermediates, offering high purity and scalable manufacturing for global supply chains.
Patent CN115537405B reveals a high-efficiency ketoreductase mutant for producing chiral pharmaceutical intermediates with superior selectivity and scalable manufacturing potential.
Patent CN115873005B details high-purity perospirone intermediate synthesis ensuring safety and supply chain reliability for global pharmaceutical manufacturing partners.
Novel asymmetric phthalocyanine compound with RGD peptide for cancer targeting. Low phototoxicity, high purity synthesis for bio-imaging applications.
Patent CN113461648A discloses a streamlined 2-step synthesis for coumarin-based neuraminidase inhibitors, offering a cost-effective alternative to complex antiviral routes.
Novel rhodium-catalyzed pathway enhances purity and yield for sitagliptin intermediates, offering significant supply chain stability and cost reduction potential.
Novel microwave method for Rapamycin 40-hydroxy alkylation. Higher yield, lower cost. Reliable pharmaceutical intermediates supplier for large scale-up.